Differential antitumor activity of compounds targeting the ubiquitin-proteasome machinery in gastrointestinal stromal tumor (GIST) cells.
Scientific Reports
Rausch, Jessica L JL; Ali, Areej A AA; Lee, Donna M DM; Gebreyohannes, Yemarshet K YK; Mehalek, Keith R KR; Agha, Aya A; Patil, Sneha S SS; Tolstov, Yanis Y; Wellens, Jasmien J; Dhillon, Harbir S HS; Makielski, Kathleen R KR; Debiec-Rychter, Maria M; Schöffski, Patrick P; Wozniak, Agnieszka A; Duensing, Anette A
Anti-KIT DNA Aptamer for Targeted Labeling of Gastrointestinal Stromal Tumor.
Molecular Cancer Therapeutics
Banerjee, Sudeep S; Yoon, Hyunho H; Yebra, Mayra M; Tang, Chih-Min CM; Gilardi, Mara M; Shankara Narayanan, Jayanth S JS; White, Rebekah R RR; Sicklick, Jason K JK; Ray, Partha P
Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors.
Bmc Cancer
Serrano, César C; Vivancos, Ana A; López-Pousa, Antonio A; Matito, Judit J; Mancuso, Francesco M FM; Valverde, Claudia C; Quiroga, Sergi S; Landolfi, Stefania S; Castro, Sandra S; Dopazo, Cristina C; Sebio, Ana A; Virgili, Anna C AC; Menso, María M MM; Martín-Broto, Javier J; Sansó, Miriam M; García-Valverde, Alfonso A; Rosell, Jordi J; Fletcher, Jonathan A JA; George, Suzanne S; Carles, Joan J; Arribas, Joaquín J
HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat.
The Journal Of Pathology. Clinical Research
Angelika Ihle, Michaela M; Merkelbach-Bruse, Sabine S; Hartmann, Wolfgang W; Bauer, Sebastian S; Ratner, Nancy N; Sonobe, Hiroshi H; Nishio, Jun J; Larsson, Olle O; Åman, Pierre P; Pedeutour, Florence F; Taguchi, Takahiro T; Wardelmann, Eva E; Buettner, Reinhard R; Schildhaus, Hans-Ulrich HU
miRNA-221 and miRNA-222 induce apoptosis via the KIT/AKT signalling pathway in gastrointestinal stromal tumours.
Molecular Oncology
Ihle, Michaela Angelika MA; Trautmann, Marcel M; Kuenstlinger, Helen H; Huss, Sebastian S; Heydt, Carina C; Fassunke, Jana J; Wardelmann, Eva E; Bauer, Sebastian S; Schildhaus, Hans-Ulrich HU; Buettner, Reinhard R; Merkelbach-Bruse, Sabine S
The HSP90 inhibitor, AT13387, is effective against imatinib-sensitive and -resistant gastrointestinal stromal tumor models.
Molecular Cancer Therapeutics
Smyth, Tomoko T; Van Looy, Thomas T; Curry, Jayne E JE; Rodriguez-Lopez, Ana M AM; Wozniak, Agnieszka A; Zhu, Meijun M; Donsky, Rachel R; Morgan, Jennifer G JG; Mayeda, Mark M; Fletcher, Jonathan A JA; Schöffski, Patrick P; Lyons, John J; Thompson, Neil T NT; Wallis, Nicola G NG